In 555 adults and adolescents with drug susceptible tuberculosis in Buenos Aires, adding a digital adherence app with weekly urine isoniazid tests to standard care raised treatment success (82% v 74%; RR 1.10, 1.00 to 1.20; 525 analysed) and lowered loss to follow-up (17% v 24%).
RCTn = 555
Rubinstein et al. Evaluation of patient centred digital adherence technology for tuberculosis treatment outcomes: pragmatic randomised controlled trial